• SENSEX 81,451.01
    -182.01 (--0.22%)
  • BANKNIFTY 55,749.70
    203.65 (+0.37%)
  • Suzlon Energy
    74.30 86.04(%)
  • Reliance Power
    60.50 60.50(%)
  • Swiggy
    338.00 617.00(%)
  • Mazagon Dock
    3,450.00 1,200.00(%)
  • Eternal Ltd
    243.00 304.50(%)
  • MMTC
    88.20 131.88(%)
  • Garden Reach Sh.
    2,926.85 1,148.10(%)
  • Waaree Energies
    2,956.60 1,808.65(%)
  • Indian Energy Ex
    203.20 244.35(%)
  • Bharat Dynamics
    2,096.00 2,096.00(%)
  • Engineers India
    239.00 304.00(%)
  • NBCC
    126.41 139.83(%)
  • IFCI
    66.71 35.67(%)
  • Muthoot Finance
    2,241.75 2,444.65(%)
  • HDFC Bank
    1,948.60 1,977.95(%)
  • LMW
    16,640.85 13,456.85(%)
  • Hind.Aeronautics
    4,962.00 3,045.95(%)
  • Pidilite Inds.
    3,127.25 3,414.40(%)
  • Infosys
    1,555.10 1,307.10(%)
  • Ola Electric
    48.07 45.55(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Aarey Drugs & Pharmaceuticals Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Indian Private
  • BSE Code : 3360.0
  • ISIN : INE198H01019
54.08 0 (0.24%)
  • As on 31 May 2025 (EOD)

  • Today’s Low

    52.55

  • Today’s High

    54.20

  • Open

    52.87

  • Perv Close

    53.95

  • 52W Low

    31.35

  • 52W High

    74.80

Key Indicators

  • P/E(TTM)

    27.07

  • Mar.Cap (₹Cr.)

    153.34

  • Div & Yield %

    0.00

  • Book Value(₹)

    48.32

  • Debt-Equity Ratio

    0.24

  • AGM Date

    30-May-2025

  • EPS

    2.01

  • P/E Ratio

    27.07

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    153.34

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    28.35

  • BV (₹)

    48.30

  • Sales( ₹ in Cr.)

    395.62

  • NP (in Cr.)

    4.68

  • NP Var(%)

    24.0

  • Div%

    0.0

  • CPS (₹)

    2.30

  • EPS (₹)

    1.70

  • Traded Value (₹ in Lakhs)

    154.28

  • 52 Week High

    74.80

  • 52 Week Low

    31.35

  • Price BSE

    54.0

  • Price NSE

    54.00

  • Market Capital( in Cr.)

    154.28

  • P/C Ratio

    24.00

  • P/E Ratio

    32.70

  • Price Vs.BV

    1.70

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 395.62 418.96 492.76 348.42 300.09 354.74
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 395.62 418.96 492.76 348.42 300.09 354.74
Other Income 6.96 2.73 2.67 7.01 6.69 4.34
Stock Adjustments 5.86 15.14 -4.77 1.46 -4.25 6.48
Total Income 408.44 436.83 490.66 356.89 302.53 365.56
EXPENDITURE :            
Raw Materials 387.76 418.98 461.35 335.96 285.93 347.45
Power and Fuel Cost 0.03 0.03 0.04 0.00 0.01 0.04
Employee Cost 0.54 0.63 0.67 0.20 0.29 0.37
Other Manufacturing Expenses 0.60 1.50 7.15 4.99 1.31 1.65
Selling and Administration Expenses 7.83 4.52 6.89 3.88 4.94 3.82
Miscellaneous Expenses 0.26 0.71 0.50 0.20 0.12 0.01
Employee Benefit Expenses 0.54 0.63 0.67 0.20 0.29 0.37
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 397.03 426.37 476.60 345.23 292.61 353.33
Operating Profit 11.42 10.45 14.07 11.66 9.93 12.22
Interest 4.38 2.87 2.04 2.44 1.79 2.23
Gross Profit 7.04 7.58 12.03 9.22 8.14 9.99
Depreciation 1.70 1.57 1.99 0.92 0.89 1.01
Profit Before Tax 5.34 6.01 10.04 8.30 7.25 8.98
Current Tax 1.33 2.28 3.59 1.66 1.50 2.25
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.67 -0.04 -0.11 0.12 -0.05 0.19
Reported Net Profit 4.68 3.77 6.55 6.51 5.79 6.54
Extraordinary Items 0.00 0.00 0.00 0.00 0.00 0.00
Adjusted Net Profit 4.68 3.77 6.55 6.51 5.79 6.54
Adjustment below Net Profit 0.00 0.00 -0.01 0.00 0.00 0.00
P & L Balance brought forward 48.42 44.65 38.11 31.59 25.80 19.49
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.23
P & L Balance carried down 53.11 48.42 44.65 38.11 31.59 25.80
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 1.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.10
Earnings Per Share-Unit Curr 1.67 1.49 2.58 2.79 2.48 2.80
Earnings Per Share(Adj)-Unit Curr 1.67 1.49 2.58 2.79 2.48 2.80
Book Value 45.57 44.43 43.85 41.29 38.50 36.02
Book Value(Adj)-Unit Curr 45.57 44.43 43.85 41.29 38.50 36.02

Shareholding Pattern

  • Promoter Group

    44.80%

  • Public Share Holding

    55.20%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 4,020,000 14.18 4,020,000 2
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 8,682,443 30.62 8,682,443 5
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 12,702,443 44.80 12,702,443 7
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 663,105 2.34 663,105 1
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 663,105 2.34 663,105 1
2] Non Institution
Bodies Corporate 1,143,736 4.03 1,122,256 88
Clearing Members 1,270 0.00 1,270 1
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 223,036 0.79 223,036 98
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 635,902 2.24 635,902 237
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 7,049,224 24.86 7,049,224 83
Individuals holding nominal share capital up to Rs. 1 lakh 5,935,587 20.93 5,445,268 15,742
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 14,988,755 52.86 14,476,956 16,249
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 28,354,303 100.00 27,842,504 16,257

Company Background

Aarey Drugs & Pharmaceuticals LtdPharmaceuticals - Indian - Bulk Drugs

  • Aarey Drugs & Pharmaceuticals Ltd
  • BSE Code : 3360.0
  • ISIN : INE198H01019

  • Incorporation Year

    1990

  • Registered Office

    E-34 MIDC Tarapur
    Boisar, Thane,
    Maharashtra-401506

  • Telephone

    91-22-23455543

  • FAX

  • Chairman

    Mihir R Ghatalia

  • Managing Director

    Mihir R Ghatalia

  • Company Secretary

    KAILASH CHAND JETHLIA

  • Auditor

    Motilal & Associates LLP

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Aarey Drugs & Pharmaceuticals Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Aarey Drugs 54.41 402.58 395.62 27.07 6.09
Abbott India 30,453.15 6,097.18 5,848.91 45.75 44.71
Astrazeneca Phar 7,965.20 1,330.33 1,295.53 205.34 33.26
P & G Health Ltd 5,775.85 1,166.89 1,151.26 40.53 39.76
Glaxosmi. Pharma 3,295.00 3,530.73 3,407.25 60.74 44.44
Cipla 1,464.85 17,645.00 16,574.34 22.94 20.10
Amrutanjan Healt 711.95 437.58 421.23 40.50 20.84
Fermenta Biotec. 311.95 315.24 307.09 13.58 4.10
Guj. Themis Bio. 307.95 174.19 169.82 68.74 44.82
Bliss GVS Pharma 131.10 638.96 605.46 20.02 11.19
Ambalal Sarabhai 37.87 11.70 3.81 16.18 1.92